{
  "id": "cluster_23_doc4",
  "content": "Clinical trial NCT04560123 at Coastal Immunology Center enrolled 142 participants with refractory neuromuscular conditions. Interim analysis showed 68% reduction in crisis episodes with biweekly Gammagard infusions. Research team: Principal Investigator Dr. R. Srinivasan, Sub-Investigator Dr. E. Marsh. IRB approval granted through 06/2025.",
  "metadata": {
    "format": "research_note"
  }
}